Premier Biomedical, Inc. is a research-based firm that develops cures for Amyotrophic Lateral Sclerosis (ALS), Traumatic Brain Injury (TBI), Multiple Sclerosis (MS), Clinical Depression, Alzheimer’s Disease, Blood Sepsis, Atherosclerosis, and Cancer. 

TypePublic
HQJackson Center, US
Founded2010
Websitepremierbiomedical.com
Premier Biomedical was founded in 2010 and is headquartered in Jackson Center, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Premier Biomedical Office Locations

Premier Biomedical has an office in Jackson Center
Show all (1)
Report incorrect company information

Premier Biomedical Financials and Metrics

Premier Biomedical Revenue

Premier Biomedical's revenue was reported to be $39.76 k in FY, 2017
USD

Revenue (Q2, 2018)

22.5k

Gross profit (Q2, 2018)

6.3k

Gross profit margin (Q2, 2018), %

27.9%

Net income (Q2, 2018)

466.3k

Market capitalization (8-Oct-2018)

448.4k

Cash (30-Jun-2018)

10.3k
Premier Biomedical's current market capitalization is $448.4 k.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

39.8k

Cost of goods sold

25.4k

Gross profit

14.3k

Gross profit Margin, %

36%
Quarterly
USDQ1, 2014Q2, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q3, 2017Q1, 2018Q2, 2018

Revenue

24.3k10.4k22.5k

Cost of goods sold

11.1k6.1k16.2k

Gross profit

13.2k4.3k6.3k

Gross profit Margin, %

54%42%28%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

15.8k102.6k35.4k22.4k83.7k

Accounts Receivable

171.5m312.0

Inventories

84.8k

Current Assets

21.8k115.5k66.5k33.9k203.6k
Quarterly
USDQ1, 2014Q2, 2014Q3, 2017Q1, 2018Q2, 2018

Cash

113.6k199.4k102.5k79.2k10.3k

Accounts Receivable

834.0

Inventories

108.0k79.4k123.4k

Current Assets

119.1k231.7k218.8k192.0k169.5k
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(4.9m)(1.4m)(2.6m)(1.8m)(3.8m)

Depreciation and Amortization

767.0954.01.5k2.1k2.3k

Inventories

(84.8k)

Accounts Payable

33.7k25.2k40.8k32.5k126.1k
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2018

Net Income

(307.3k)(209.8k)(936.6k)(188.8k)(415.1k)(722.1k)(435.1k)566.3k

Depreciation and Amortization

233.0466.0591.0

Inventories

5.4k

Accounts Payable

(104.6k)(79.6k)34.6k209.5k237.9k299.4k83.4k143.7k210.1k42.0
USDY, 2018

Financial Leverage

-0.1 x
Show all financial metrics
Report incorrect company information

Premier Biomedical Online and Social Media Presence

Embed Graph
Report incorrect company information

Premier Biomedical News and Updates

Premier Biomedical, Inc. Discusses CBD Public Image Challenges and the Future Marketplace with Uptick Newswire’s Stock Day Podcast

PHOENIX, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTCQB:BIEI) (“Premier Biomedical, Inc.” or the “company”) is looking for new strategies and joint ventures to sell CBD. CEO and President of Premier Biomedical, Inc., William A. Hartman, talked with Stock Day’s Everett Jolly abou…
Report incorrect company information

Premier Biomedical Company Life and Culture

Report incorrect company information